In addition, documentation of the GISEs was taken from the medical records, which might have some factual bias
10.1002/brb3.3508 Summary Keywords oxidative stress, biomarkers, hypertension, diabetes, disease progression, antioxidant therapy, clinical trials, precision redox medicine Citation Nuez-Selles AJ, Nuez-Musa RA and Guillen-Marmolejos RA (2025) Linking oxidative stress biomarkers to disease progression and antioxidant therapy in hypertension and diabetes mellitus
Medical Guidelines on Transitioning from One to the Other Medical guidelines generally recommend that any switch between these medications should be managed under the supervision of a healthcare provider
Programme data have reported, for example, higher mean weight loss at 72 weeks with a GIP/GLP-1 regimen than with some GLP-1-only arms at different time pointscontext, population, and rescue/adherence rules all matter
Study Details Source Related Guidelines: Pharmacological Management of United States Adults with Overweight or Obesity The Obesity Society (TOS), Obesity Medicine Association (OMA), Obesity Action Coalition (OAC), March 2026 Management of Adult Overweight and Obesity Veterans Health Administration / Department of Defense (VA/DOD), November 2025 Sign up for alerts and stay informed on the latest published guidelines.
Supplementation with NAD+ precursors for treating alzheimer's disease: a metabolic approach
